Search

Displaying results 6541 - 6550 of 9325 in total
  1. Drug

    Muvadenant

    go.drugbank.com/drugs/DB21684
    Experimental

    The usage of the INN stem '-adenant' in the name indicates that Muvadenant is a adenosin receptor antagonist. Muvadenant has a monoisotopic molecular weight of 430.17 Da.

  2. Drug

    Darbinurad

    go.drugbank.com/drugs/DB21695
    Experimental

    The usage of the INN stem '-inurad' in the name indicates that Darbinurad is a urate transporter inhibitor. Darbinurad has a monoisotopic molecular weight of 324.09 Da.

  3. Drug

    Remlifanserin

    go.drugbank.com/drugs/DB21707
    Experimental

    The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist. Remlifanserin has a monoisotopic molecular weight of 429.22 Da.

  4. Drug

    Envudeucitinib

    go.drugbank.com/drugs/DB21716
    Investigational

    The usage of the INN stem '-citinib' in the name indicates that Envudeucitinib is a Janus kinase inhibitor. Envudeucitinib has a monoisotopic molecular weight of 426.23 Da.

  5. Drug

    Zemprocitinib

    go.drugbank.com/drugs/DB21719
    Experimental

    The usage of the INN stem '-citinib' in the name indicates that Zemprocitinib is a Janus kinase inhibitor. Zemprocitinib has a monoisotopic molecular weight of 345.13 Da.

  6. Drug

    Alunacedase alfa

    go.drugbank.com/drugs/DB15736
    Investigational

    This recombinant version of the enzyme has antihypertensive and potential antineoplastic activities.

  7. Drug

    D-norleucine

    go.drugbank.com/drugs/DB04419
    Experimental

    An unnatural amino acid that is used experimentally to study protein structure and function. It is structurally similar to METHIONINE, however it does not contain SULFUR.

  8. Drug

    Sphingosine

    go.drugbank.com/drugs/DB03203
    Investigational

    Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed)

  9. Drug

    AGT-182

    go.drugbank.com/drugs/DB17630
    Investigational

    AGT-182 is an investigational enzyme replacement therapy engineered by the fusion of the iduronate-2-sulfatase (IDS) enzyme and a human insulin receptor monoclonal antibody.

  10. Drug

    BMS-817399

    go.drugbank.com/drugs/DB14941
    Investigational

    BMS-817399 is under investigation in clinical trial NCT01404585 (Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis).